

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cytidine metabolic process (GO:0046087) | 6.20551043 |
| 2 | cytidine catabolic process (GO:0006216) | 6.20551043 |
| 3 | cytidine deamination (GO:0009972) | 6.20551043 |
| 4 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 5.90821589 |
| 5 | DNA deamination (GO:0045006) | 5.53868261 |
| 6 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 4.70786633 |
| 7 | eosinophil chemotaxis (GO:0048245) | 4.22574124 |
| 8 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.86068036 |
| 9 | eosinophil migration (GO:0072677) | 3.81215327 |
| 10 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.65660971 |
| 11 | ATP synthesis coupled proton transport (GO:0015986) | 3.65660971 |
| 12 | regulation of regulatory T cell differentiation (GO:0045589) | 3.59050627 |
| 13 | actin nucleation (GO:0045010) | 3.54481656 |
| 14 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.53929261 |
| 15 | protein neddylation (GO:0045116) | 3.51403873 |
| 16 | immunoglobulin mediated immune response (GO:0016064) | 3.50992858 |
| 17 | pyrimidine nucleoside catabolic process (GO:0046135) | 3.46019270 |
| 18 | platelet dense granule organization (GO:0060155) | 3.44130662 |
| 19 | cellular response to exogenous dsRNA (GO:0071360) | 3.31973237 |
| 20 | regulation of activation of Janus kinase activity (GO:0010533) | 3.20431246 |
| 21 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.11952466 |
| 22 | sequestering of actin monomers (GO:0042989) | 3.10243777 |
| 23 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.10081877 |
| 24 | regulation of chronic inflammatory response (GO:0002676) | 3.00746576 |
| 25 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.87370400 |
| 26 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.84491035 |
| 27 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.84491035 |
| 28 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.83084582 |
| 29 | positive regulation of calcium-mediated signaling (GO:0050850) | 2.80646572 |
| 30 | positive regulation of antigen processing and presentation (GO:0002579) | 2.79363176 |
| 31 | positive regulation of lymphocyte migration (GO:2000403) | 2.78101350 |
| 32 | positive regulation of interleukin-8 secretion (GO:2000484) | 2.76179955 |
| 33 | B cell mediated immunity (GO:0019724) | 2.75704803 |
| 34 | response to interferon-beta (GO:0035456) | 2.73733517 |
| 35 | negative regulation of mast cell activation (GO:0033004) | 2.73448492 |
| 36 | negative regulation of viral genome replication (GO:0045071) | 2.73193771 |
| 37 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.72120009 |
| 38 | positive regulation of prostaglandin secretion (GO:0032308) | 2.71687237 |
| 39 | regulation of antigen processing and presentation (GO:0002577) | 2.71184665 |
| 40 | regulation of interleukin-8 secretion (GO:2000482) | 2.70466037 |
| 41 | positive regulation of interleukin-17 production (GO:0032740) | 2.68448808 |
| 42 | positive thymic T cell selection (GO:0045059) | 2.67052961 |
| 43 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.66740053 |
| 44 | positive regulation of T cell migration (GO:2000406) | 2.64665165 |
| 45 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.63375192 |
| 46 | negative regulation of T cell apoptotic process (GO:0070233) | 2.62966212 |
| 47 | positive regulation of defense response to virus by host (GO:0002230) | 2.62581809 |
| 48 | T cell costimulation (GO:0031295) | 2.62166540 |
| 49 | positive regulation of tyrosine phosphorylation of Stat5 protein (GO:0042523) | 2.61830941 |
| 50 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.60197579 |
| 51 | lymphocyte costimulation (GO:0031294) | 2.59467730 |
| 52 | positive regulation of respiratory burst (GO:0060267) | 2.58603712 |
| 53 | pyrimidine-containing compound catabolic process (GO:0072529) | 2.57763151 |
| 54 | natural killer cell activation involved in immune response (GO:0002323) | 2.56530940 |
| 55 | electron transport chain (GO:0022900) | 2.54661615 |
| 56 | respiratory electron transport chain (GO:0022904) | 2.54463314 |
| 57 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.53091049 |
| 58 | positive regulation of activated T cell proliferation (GO:0042104) | 2.53080981 |
| 59 | negative regulation by host of viral transcription (GO:0043922) | 2.52616928 |
| 60 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.50729842 |
| 61 | amine catabolic process (GO:0009310) | 2.49570755 |
| 62 | cellular biogenic amine catabolic process (GO:0042402) | 2.49570755 |
| 63 | leukocyte degranulation (GO:0043299) | 2.48025375 |
| 64 | cellular response to zinc ion (GO:0071294) | 2.43973145 |
| 65 | protein complex biogenesis (GO:0070271) | 2.43115460 |
| 66 | positive regulation of interferon-gamma production (GO:0032729) | 2.41089503 |
| 67 | granulocyte activation (GO:0036230) | 2.39959460 |
| 68 | hydrogen ion transmembrane transport (GO:1902600) | 2.39662883 |
| 69 | regulation of T cell tolerance induction (GO:0002664) | 2.39335325 |
| 70 | regulation of cellular extravasation (GO:0002691) | 2.39275773 |
| 71 | killing of cells of other organism (GO:0031640) | 2.38425964 |
| 72 | disruption of cells of other organism (GO:0044364) | 2.38425964 |
| 73 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.38369709 |
| 74 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.37719595 |
| 75 | regulation of T cell migration (GO:2000404) | 2.36906943 |
| 76 | proton transport (GO:0015992) | 2.36759634 |
| 77 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.36461833 |
| 78 | neutrophil activation (GO:0042119) | 2.36408952 |
| 79 | neutrophil activation involved in immune response (GO:0002283) | 2.36060875 |
| 80 | cellular response to interferon-beta (GO:0035458) | 2.35603940 |
| 81 | regulation of immunoglobulin secretion (GO:0051023) | 2.35411418 |
| 82 | mast cell activation (GO:0045576) | 2.35114320 |
| 83 | negative regulation of lymphocyte apoptotic process (GO:0070229) | 2.35058956 |
| 84 | positive regulation of B cell differentiation (GO:0045579) | 2.34459896 |
| 85 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.33028304 |
| 86 | behavioral response to nicotine (GO:0035095) | 2.32650250 |
| 87 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.32287265 |
| 88 | hydrogen transport (GO:0006818) | 2.31742130 |
| 89 | tryptophan catabolic process (GO:0006569) | 2.31390018 |
| 90 | indole-containing compound catabolic process (GO:0042436) | 2.31390018 |
| 91 | indolalkylamine catabolic process (GO:0046218) | 2.31390018 |
| 92 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.28241255 |
| 93 | regulation of defense response to virus by host (GO:0050691) | 2.27246752 |
| 94 | regulation of interleukin-1 beta secretion (GO:0050706) | 2.25790185 |
| 95 | pyrimidine ribonucleoside metabolic process (GO:0046131) | 2.24690019 |
| 96 | positive regulation of T cell apoptotic process (GO:0070234) | 2.24109379 |
| 97 | positive regulation of interleukin-1 secretion (GO:0050716) | 2.23970100 |
| 98 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.23417491 |
| 99 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.23417491 |
| 100 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.22092574 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.44095049 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.74190179 |
| 3 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.05667625 |
| 4 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 3.30866244 |
| 5 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.05770228 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.85202356 |
| 7 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.49578199 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.39321165 |
| 9 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.35672553 |
| 10 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.26582457 |
| 11 | VDR_22108803_ChIP-Seq_LS180_Human | 2.26544665 |
| 12 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.16205887 |
| 13 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.01441474 |
| 14 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.85036563 |
| 15 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.79228848 |
| 16 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.74882147 |
| 17 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.69756642 |
| 18 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.57843625 |
| 19 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.57326734 |
| 20 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.57287754 |
| 21 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.56798191 |
| 22 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.56560261 |
| 23 | GATA3_26560356_Chip-Seq_TH2_Human | 1.54386609 |
| 24 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.54323465 |
| 25 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.53002782 |
| 26 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.52175678 |
| 27 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51736134 |
| 28 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.49964289 |
| 29 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.47947728 |
| 30 | MYB_26560356_Chip-Seq_TH2_Human | 1.47063457 |
| 31 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.46377292 |
| 32 | AR_20517297_ChIP-Seq_VCAP_Human | 1.44376474 |
| 33 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.43722359 |
| 34 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.37548620 |
| 35 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.37466470 |
| 36 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.35638835 |
| 37 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.32918661 |
| 38 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.31675965 |
| 39 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.31031978 |
| 40 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.30254063 |
| 41 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.30254063 |
| 42 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.26156602 |
| 43 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.25845102 |
| 44 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.24389867 |
| 45 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.24056693 |
| 46 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.23066080 |
| 47 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.22943514 |
| 48 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.20577646 |
| 49 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.20149746 |
| 50 | NCOR_22424771_ChIP-Seq_293T_Human | 1.19629189 |
| 51 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.19477256 |
| 52 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.19477256 |
| 53 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.19081873 |
| 54 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.17836556 |
| 55 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.17718641 |
| 56 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 1.17642987 |
| 57 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 1.15838961 |
| 58 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.15143408 |
| 59 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.15130284 |
| 60 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.14339891 |
| 61 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.12276122 |
| 62 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.11945514 |
| 63 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.11706994 |
| 64 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.09202771 |
| 65 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.09126666 |
| 66 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.08823499 |
| 67 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08676067 |
| 68 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.08340756 |
| 69 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.08306644 |
| 70 | P53_21459846_ChIP-Seq_SAOS-2_Human | 1.07603009 |
| 71 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.07132095 |
| 72 | P300_27268052_Chip-Seq_Bcells_Human | 1.06045725 |
| 73 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.05821655 |
| 74 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.05265173 |
| 75 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.04168445 |
| 76 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.03633575 |
| 77 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.03128869 |
| 78 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.02829199 |
| 79 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 1.02780528 |
| 80 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.00512906 |
| 81 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.00330183 |
| 82 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.99991084 |
| 83 | ERA_21632823_ChIP-Seq_H3396_Human | 0.99396155 |
| 84 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.98697604 |
| 85 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.97485565 |
| 86 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.96510571 |
| 87 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.95360622 |
| 88 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.95109896 |
| 89 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.94584501 |
| 90 | SA1_27219007_Chip-Seq_Bcells_Human | 0.94458379 |
| 91 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.92964648 |
| 92 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.92504990 |
| 93 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.91338272 |
| 94 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.91295029 |
| 95 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.91078204 |
| 96 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.88276162 |
| 97 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.84385406 |
| 98 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83684627 |
| 99 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.83538179 |
| 100 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.83455795 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 3.82577092 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.56944731 |
| 3 | MP0005084_abnormal_gallbladder_morpholo | 3.25349248 |
| 4 | MP0003724_increased_susceptibility_to | 2.95015157 |
| 5 | MP0002148_abnormal_hypersensitivity_rea | 2.80126373 |
| 6 | MP0009785_altered_susceptibility_to | 2.52675719 |
| 7 | MP0004147_increased_porphyrin_level | 2.32932722 |
| 8 | MP0005464_abnormal_platelet_physiology | 2.27142431 |
| 9 | MP0005000_abnormal_immune_tolerance | 2.16059067 |
| 10 | MP0005360_urolithiasis | 2.13294810 |
| 11 | MP0001790_abnormal_immune_system | 2.10576400 |
| 12 | MP0005387_immune_system_phenotype | 2.10576400 |
| 13 | MP0006082_CNS_inflammation | 2.09458259 |
| 14 | MP0001800_abnormal_humoral_immune | 2.05176591 |
| 15 | MP0009764_decreased_sensitivity_to | 1.99659619 |
| 16 | MP0005025_abnormal_response_to | 1.97899130 |
| 17 | MP0003806_abnormal_nucleotide_metabolis | 1.95857732 |
| 18 | MP0010155_abnormal_intestine_physiology | 1.91629567 |
| 19 | MP0003252_abnormal_bile_duct | 1.85653906 |
| 20 | MP0002723_abnormal_immune_serum | 1.83577497 |
| 21 | MP0005645_abnormal_hypothalamus_physiol | 1.81550512 |
| 22 | MP0002452_abnormal_antigen_presenting | 1.69759158 |
| 23 | MP0002420_abnormal_adaptive_immunity | 1.68862144 |
| 24 | MP0001819_abnormal_immune_cell | 1.67776158 |
| 25 | MP0003866_abnormal_defecation | 1.62686299 |
| 26 | MP0000372_irregular_coat_pigmentation | 1.59256901 |
| 27 | MP0000465_gastrointestinal_hemorrhage | 1.59010430 |
| 28 | MP0000685_abnormal_immune_system | 1.56403231 |
| 29 | MP0009333_abnormal_splenocyte_physiolog | 1.53772118 |
| 30 | MP0001919_abnormal_reproductive_system | 1.53074322 |
| 31 | MP0002139_abnormal_hepatobiliary_system | 1.52700522 |
| 32 | MP0001873_stomach_inflammation | 1.52416906 |
| 33 | MP0003436_decreased_susceptibility_to | 1.52413281 |
| 34 | MP0001845_abnormal_inflammatory_respons | 1.50009919 |
| 35 | MP0008872_abnormal_physiological_respon | 1.48991083 |
| 36 | MP0002876_abnormal_thyroid_physiology | 1.46994020 |
| 37 | MP0005646_abnormal_pituitary_gland | 1.46278924 |
| 38 | MP0009379_abnormal_foot_pigmentation | 1.44675296 |
| 39 | MP0002166_altered_tumor_susceptibility | 1.41473363 |
| 40 | MP0002419_abnormal_innate_immunity | 1.39506079 |
| 41 | MP0002095_abnormal_skin_pigmentation | 1.37343659 |
| 42 | MP0002102_abnormal_ear_morphology | 1.32466680 |
| 43 | MP0003646_muscle_fatigue | 1.32445913 |
| 44 | MP0008995_early_reproductive_senescence | 1.32227915 |
| 45 | MP0002138_abnormal_hepatobiliary_system | 1.25233851 |
| 46 | MP0008875_abnormal_xenobiotic_pharmacok | 1.23618482 |
| 47 | MP0000716_abnormal_immune_system | 1.23471751 |
| 48 | MP0002736_abnormal_nociception_after | 1.21608009 |
| 49 | MP0005085_abnormal_gallbladder_physiolo | 1.20690615 |
| 50 | MP0001905_abnormal_dopamine_level | 1.19761608 |
| 51 | MP0002006_tumorigenesis | 1.17778594 |
| 52 | MP0002398_abnormal_bone_marrow | 1.16194116 |
| 53 | MP0003011_delayed_dark_adaptation | 1.14359317 |
| 54 | MP0001968_abnormal_touch/_nociception | 1.12769971 |
| 55 | MP0008469_abnormal_protein_level | 1.12520668 |
| 56 | MP0002877_abnormal_melanocyte_morpholog | 1.11181166 |
| 57 | MP0002837_dystrophic_cardiac_calcinosis | 1.09724388 |
| 58 | MP0002822_catalepsy | 1.08996057 |
| 59 | MP0009840_abnormal_foam_cell | 1.07779465 |
| 60 | MP0003763_abnormal_thymus_physiology | 1.07397330 |
| 61 | MP0001663_abnormal_digestive_system | 1.06578866 |
| 62 | MP0001853_heart_inflammation | 1.04789586 |
| 63 | MP0005075_abnormal_melanosome_morpholog | 1.04513179 |
| 64 | MP0003303_peritoneal_inflammation | 1.04179657 |
| 65 | MP0005389_reproductive_system_phenotype | 1.02566803 |
| 66 | MP0002429_abnormal_blood_cell | 1.01059385 |
| 67 | MP0000689_abnormal_spleen_morphology | 1.00033864 |
| 68 | MP0002653_abnormal_ependyma_morphology | 0.99733192 |
| 69 | MP0004019_abnormal_vitamin_homeostasis | 0.99134108 |
| 70 | MP0005636_abnormal_mineral_homeostasis | 0.99027930 |
| 71 | MP0005410_abnormal_fertilization | 0.98781093 |
| 72 | MP0002405_respiratory_system_inflammati | 0.97665102 |
| 73 | MP0001764_abnormal_homeostasis | 0.96373785 |
| 74 | MP0003195_calcinosis | 0.94973718 |
| 75 | MP0006276_abnormal_autonomic_nervous | 0.93162011 |
| 76 | MP0005166_decreased_susceptibility_to | 0.92714220 |
| 77 | MP0005551_abnormal_eye_electrophysiolog | 0.91865071 |
| 78 | MP0001533_abnormal_skeleton_physiology | 0.91374242 |
| 79 | MP0002277_abnormal_respiratory_mucosa | 0.90522135 |
| 80 | MP0009763_increased_sensitivity_to | 0.90028430 |
| 81 | MP0006072_abnormal_retinal_apoptosis | 0.89355946 |
| 82 | MP0000230_abnormal_systemic_arterial | 0.89281087 |
| 83 | MP0005381_digestive/alimentary_phenotyp | 0.89109592 |
| 84 | MP0000343_altered_response_to | 0.88837838 |
| 85 | MP0005167_abnormal_blood-brain_barrier | 0.88511051 |
| 86 | MP0009643_abnormal_urine_homeostasis | 0.87950680 |
| 87 | MP0008004_abnormal_stomach_pH | 0.87590095 |
| 88 | MP0001501_abnormal_sleep_pattern | 0.87191319 |
| 89 | MP0003878_abnormal_ear_physiology | 0.85023424 |
| 90 | MP0005377_hearing/vestibular/ear_phenot | 0.85023424 |
| 91 | MP0002722_abnormal_immune_system | 0.84763587 |
| 92 | MP0001666_abnormal_nutrient_absorption | 0.84621618 |
| 93 | MP0005408_hypopigmentation | 0.84420043 |
| 94 | MP0001664_abnormal_digestion | 0.84198982 |
| 95 | MP0003186_abnormal_redox_activity | 0.83322453 |
| 96 | MP0004142_abnormal_muscle_tone | 0.82893410 |
| 97 | MP0002733_abnormal_thermal_nociception | 0.82155906 |
| 98 | MP0005332_abnormal_amino_acid | 0.81734559 |
| 99 | MP0003787_abnormal_imprinting | 0.81365894 |
| 100 | MP0003075_altered_response_to | 0.79850565 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.59854467 |
| 2 | Alveolar cell carcinoma (HP:0006519) | 3.75617274 |
| 3 | Mitochondrial inheritance (HP:0001427) | 3.46282412 |
| 4 | Acute necrotizing encephalopathy (HP:0006965) | 3.39358434 |
| 5 | Aplastic anemia (HP:0001915) | 3.26945651 |
| 6 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.20053426 |
| 7 | Neoplasm of the tracheobronchial system (HP:0100552) | 3.19549995 |
| 8 | IgG deficiency (HP:0004315) | 3.16493636 |
| 9 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.07519526 |
| 10 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 3.05012087 |
| 11 | Hepatocellular necrosis (HP:0001404) | 3.04327528 |
| 12 | Hepatic necrosis (HP:0002605) | 3.01488827 |
| 13 | Stomatitis (HP:0010280) | 2.98407407 |
| 14 | Increased intramyocellular lipid droplets (HP:0012240) | 2.96906464 |
| 15 | Acute encephalopathy (HP:0006846) | 2.96641118 |
| 16 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.89855161 |
| 17 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.89855161 |
| 18 | Pulmonary infiltrates (HP:0002113) | 2.88542429 |
| 19 | Increased CSF lactate (HP:0002490) | 2.86457439 |
| 20 | Congenital stationary night blindness (HP:0007642) | 2.85068218 |
| 21 | Hypoproteinemia (HP:0003075) | 2.81105335 |
| 22 | Progressive macrocephaly (HP:0004481) | 2.79729111 |
| 23 | Abnormality of the prostate (HP:0008775) | 2.77240197 |
| 24 | Decreased central vision (HP:0007663) | 2.75669452 |
| 25 | 3-Methylglutaconic aciduria (HP:0003535) | 2.73171135 |
| 26 | Petechiae (HP:0000967) | 2.71832211 |
| 27 | Increased IgM level (HP:0003496) | 2.69465392 |
| 28 | Increased muscle lipid content (HP:0009058) | 2.66979024 |
| 29 | Increased hepatocellular lipid droplets (HP:0006565) | 2.63973888 |
| 30 | Abnormality of T cell number (HP:0011839) | 2.62181415 |
| 31 | Obstructive lung disease (HP:0006536) | 2.61235622 |
| 32 | Chronic obstructive pulmonary disease (HP:0006510) | 2.61235622 |
| 33 | Lipid accumulation in hepatocytes (HP:0006561) | 2.60437361 |
| 34 | T lymphocytopenia (HP:0005403) | 2.59660608 |
| 35 | Abnormality of T cells (HP:0002843) | 2.58599763 |
| 36 | Chronic diarrhea (HP:0002028) | 2.52305665 |
| 37 | Generalized aminoaciduria (HP:0002909) | 2.52305167 |
| 38 | Renal Fanconi syndrome (HP:0001994) | 2.47591250 |
| 39 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.44739975 |
| 40 | Exertional dyspnea (HP:0002875) | 2.40301599 |
| 41 | Abolished electroretinogram (ERG) (HP:0000550) | 2.40194724 |
| 42 | Abnormality of urine glucose concentration (HP:0011016) | 2.37904242 |
| 43 | Glycosuria (HP:0003076) | 2.37904242 |
| 44 | Cerebral edema (HP:0002181) | 2.36668283 |
| 45 | Meningitis (HP:0001287) | 2.34342846 |
| 46 | Hemoptysis (HP:0002105) | 2.31925677 |
| 47 | Severe combined immunodeficiency (HP:0004430) | 2.30149156 |
| 48 | Cerebral palsy (HP:0100021) | 2.26495144 |
| 49 | Abnormality of B cell number (HP:0010975) | 2.26169036 |
| 50 | Nausea (HP:0002018) | 2.21176005 |
| 51 | Lethargy (HP:0001254) | 2.20085440 |
| 52 | Purpura (HP:0000979) | 2.19069800 |
| 53 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.17664441 |
| 54 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.17651986 |
| 55 | Lactic acidosis (HP:0003128) | 2.15571368 |
| 56 | Abnormality of T cell physiology (HP:0011840) | 2.14395146 |
| 57 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.12316908 |
| 58 | Dicarboxylic aciduria (HP:0003215) | 2.12054763 |
| 59 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.12054763 |
| 60 | Chest pain (HP:0100749) | 2.06888022 |
| 61 | Autoimmune hemolytic anemia (HP:0001890) | 2.04637343 |
| 62 | Abnormality of the pleura (HP:0002103) | 2.03408538 |
| 63 | Encephalitis (HP:0002383) | 2.01603173 |
| 64 | Vasculitis (HP:0002633) | 2.01046563 |
| 65 | Methylmalonic aciduria (HP:0012120) | 2.01031838 |
| 66 | Thyroiditis (HP:0100646) | 2.01011905 |
| 67 | Increased serum ferritin (HP:0003281) | 2.00346307 |
| 68 | Myositis (HP:0100614) | 2.00296651 |
| 69 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.99123758 |
| 70 | Optic disc pallor (HP:0000543) | 1.98252271 |
| 71 | Abnormality of iron homeostasis (HP:0011031) | 1.97925912 |
| 72 | Increased serum lactate (HP:0002151) | 1.97783606 |
| 73 | Agitation (HP:0000713) | 1.96162856 |
| 74 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.95783557 |
| 75 | Abnormality of alanine metabolism (HP:0010916) | 1.95783557 |
| 76 | Hyperalaninemia (HP:0003348) | 1.95783557 |
| 77 | Tongue fasciculations (HP:0001308) | 1.95661351 |
| 78 | Hypoalbuminemia (HP:0003073) | 1.93507379 |
| 79 | Abnormal albumin level (HP:0012116) | 1.93507379 |
| 80 | Attenuation of retinal blood vessels (HP:0007843) | 1.92854077 |
| 81 | Congenital sensorineural hearing impairment (HP:0008527) | 1.92691233 |
| 82 | Type 2 muscle fiber atrophy (HP:0003554) | 1.92373070 |
| 83 | Molar tooth sign on MRI (HP:0002419) | 1.90875197 |
| 84 | Abnormality of midbrain morphology (HP:0002418) | 1.90875197 |
| 85 | Type II lissencephaly (HP:0007260) | 1.89531060 |
| 86 | Pancreatitis (HP:0001733) | 1.89344035 |
| 87 | Abnormality of eosinophils (HP:0001879) | 1.89201922 |
| 88 | B lymphocytopenia (HP:0010976) | 1.87867388 |
| 89 | Epistaxis (HP:0000421) | 1.87566635 |
| 90 | Renal cortical cysts (HP:0000803) | 1.86904843 |
| 91 | Progressive neurologic deterioration (HP:0002344) | 1.86900466 |
| 92 | Agammaglobulinemia (HP:0004432) | 1.85660276 |
| 93 | Prolonged bleeding time (HP:0003010) | 1.84453993 |
| 94 | Ketosis (HP:0001946) | 1.84169970 |
| 95 | Systemic lupus erythematosus (HP:0002725) | 1.83199209 |
| 96 | Autoimmune thrombocytopenia (HP:0001973) | 1.81789975 |
| 97 | Type I transferrin isoform profile (HP:0003642) | 1.81556709 |
| 98 | Reduced antithrombin III activity (HP:0001976) | 1.80924636 |
| 99 | Abnormality of macrophages (HP:0004311) | 1.78504585 |
| 100 | Hyperphosphaturia (HP:0003109) | 1.77876101 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 4.29653312 |
| 2 | TESK2 | 3.36085961 |
| 3 | KDR | 3.07975141 |
| 4 | BCKDK | 2.74372396 |
| 5 | TAOK3 | 2.64975320 |
| 6 | MAP4K2 | 2.59482626 |
| 7 | ADRBK2 | 2.29173235 |
| 8 | TLK1 | 2.27766635 |
| 9 | MAP4K1 | 2.00534757 |
| 10 | TEC | 1.90269869 |
| 11 | BMPR2 | 1.89945218 |
| 12 | ZAK | 1.83912102 |
| 13 | ITK | 1.80607338 |
| 14 | GRK1 | 1.80142417 |
| 15 | SYK | 1.71904713 |
| 16 | IKBKB | 1.68009174 |
| 17 | PIM2 | 1.67212612 |
| 18 | MATK | 1.65579238 |
| 19 | MST4 | 1.62870422 |
| 20 | MAP3K11 | 1.53808677 |
| 21 | TAF1 | 1.50877558 |
| 22 | VRK2 | 1.45996969 |
| 23 | MAP3K12 | 1.45927056 |
| 24 | JAK3 | 1.42011548 |
| 25 | GRK6 | 1.41578426 |
| 26 | KIT | 1.41042606 |
| 27 | FES | 1.40764121 |
| 28 | ACVR1B | 1.38635155 |
| 29 | PINK1 | 1.35534358 |
| 30 | GRK7 | 1.33678748 |
| 31 | MAP2K7 | 1.28029436 |
| 32 | RIPK4 | 1.25872419 |
| 33 | MAP3K5 | 1.23595592 |
| 34 | BTK | 1.23050942 |
| 35 | TESK1 | 1.22446782 |
| 36 | NUAK1 | 1.20156617 |
| 37 | TIE1 | 1.18112814 |
| 38 | BMPR1B | 1.17947810 |
| 39 | MYLK | 1.17866323 |
| 40 | BLK | 1.16912398 |
| 41 | PRKCI | 1.13253366 |
| 42 | LIMK1 | 1.13025439 |
| 43 | LYN | 1.10864467 |
| 44 | CSF1R | 1.09169108 |
| 45 | MAPKAPK3 | 1.02779933 |
| 46 | IKBKE | 1.00313504 |
| 47 | TBK1 | 0.99610030 |
| 48 | INSRR | 0.99016387 |
| 49 | CDK19 | 0.98307528 |
| 50 | LCK | 0.97226891 |
| 51 | FRK | 0.95425314 |
| 52 | PRKCQ | 0.94123780 |
| 53 | CSNK1G3 | 0.92814700 |
| 54 | CSK | 0.86339133 |
| 55 | DAPK1 | 0.81999567 |
| 56 | DYRK2 | 0.81880289 |
| 57 | DAPK2 | 0.78300542 |
| 58 | VRK1 | 0.76524601 |
| 59 | GRK5 | 0.75881437 |
| 60 | ZAP70 | 0.74987055 |
| 61 | MUSK | 0.74768031 |
| 62 | OXSR1 | 0.73903944 |
| 63 | STK38L | 0.73241932 |
| 64 | ADRBK1 | 0.71957335 |
| 65 | WNK3 | 0.71811832 |
| 66 | STK24 | 0.71754640 |
| 67 | RPS6KA5 | 0.69238962 |
| 68 | PIM1 | 0.67213981 |
| 69 | DAPK3 | 0.67188980 |
| 70 | CSNK1G2 | 0.65621367 |
| 71 | TRIM28 | 0.65216278 |
| 72 | SCYL2 | 0.63921941 |
| 73 | PIK3CG | 0.62152645 |
| 74 | TNK2 | 0.61122964 |
| 75 | WNK4 | 0.58368727 |
| 76 | MAPK13 | 0.57339935 |
| 77 | CSNK1A1L | 0.57147760 |
| 78 | PRKCA | 0.54983402 |
| 79 | CSNK1G1 | 0.54724671 |
| 80 | MAP3K4 | 0.53755666 |
| 81 | ABL2 | 0.50276383 |
| 82 | CAMKK2 | 0.49028400 |
| 83 | OBSCN | 0.48418957 |
| 84 | PRKACA | 0.48302696 |
| 85 | STK16 | 0.46689558 |
| 86 | IGF1R | 0.45610729 |
| 87 | PRKCD | 0.44934832 |
| 88 | ARAF | 0.43143440 |
| 89 | PRKCE | 0.42360034 |
| 90 | CAMK2A | 0.40697032 |
| 91 | ABL1 | 0.40078088 |
| 92 | BCR | 0.39965309 |
| 93 | FYN | 0.39005833 |
| 94 | PKN1 | 0.35677942 |
| 95 | MAP3K14 | 0.34704582 |
| 96 | PRKACG | 0.34621969 |
| 97 | CSNK2A1 | 0.33241647 |
| 98 | ERBB2 | 0.32656924 |
| 99 | MAP2K2 | 0.31755069 |
| 100 | AURKA | 0.31095073 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Asthma_Homo sapiens_hsa05310 | 4.03162691 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.76850714 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 3.74501439 |
| 4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.62421583 |
| 5 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 3.22981788 |
| 6 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.10318711 |
| 7 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.71067675 |
| 8 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.59166120 |
| 9 | Proteasome_Homo sapiens_hsa03050 | 2.45587110 |
| 10 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.42652211 |
| 11 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.30118409 |
| 12 | Parkinsons disease_Homo sapiens_hsa05012 | 2.14852462 |
| 13 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.94500601 |
| 14 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.92549564 |
| 15 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.91218106 |
| 16 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.90245904 |
| 17 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.78913861 |
| 18 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.75547567 |
| 19 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.45560323 |
| 20 | Viral myocarditis_Homo sapiens_hsa05416 | 1.37933263 |
| 21 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.33384442 |
| 22 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.29555977 |
| 23 | Alzheimers disease_Homo sapiens_hsa05010 | 1.27903881 |
| 24 | Protein export_Homo sapiens_hsa03060 | 1.24798179 |
| 25 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.24062386 |
| 26 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.23486386 |
| 27 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.22912961 |
| 28 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.22646545 |
| 29 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.15478628 |
| 30 | Phototransduction_Homo sapiens_hsa04744 | 1.14779337 |
| 31 | Leishmaniasis_Homo sapiens_hsa05140 | 1.14619633 |
| 32 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.12449319 |
| 33 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.10438278 |
| 34 | Huntingtons disease_Homo sapiens_hsa05016 | 1.05559869 |
| 35 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.02354436 |
| 36 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.01955709 |
| 37 | Ribosome_Homo sapiens_hsa03010 | 1.00192645 |
| 38 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.96682146 |
| 39 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.92439399 |
| 40 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.91979407 |
| 41 | Peroxisome_Homo sapiens_hsa04146 | 0.90075256 |
| 42 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.89263644 |
| 43 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.89122590 |
| 44 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.87643641 |
| 45 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.85931958 |
| 46 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.85797282 |
| 47 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.84347303 |
| 48 | RNA polymerase_Homo sapiens_hsa03020 | 0.81655695 |
| 49 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.80287373 |
| 50 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.79491915 |
| 51 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.77944283 |
| 52 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.77686702 |
| 53 | Mineral absorption_Homo sapiens_hsa04978 | 0.77556309 |
| 54 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.77428187 |
| 55 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.76624062 |
| 56 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.75507396 |
| 57 | Retinol metabolism_Homo sapiens_hsa00830 | 0.71743581 |
| 58 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.69295088 |
| 59 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.68768299 |
| 60 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.68605882 |
| 61 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.66892721 |
| 62 | Phagosome_Homo sapiens_hsa04145 | 0.65017343 |
| 63 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.64151449 |
| 64 | Olfactory transduction_Homo sapiens_hsa04740 | 0.63554140 |
| 65 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.62744985 |
| 66 | Tuberculosis_Homo sapiens_hsa05152 | 0.62702020 |
| 67 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.57209710 |
| 68 | Salmonella infection_Homo sapiens_hsa05132 | 0.54779423 |
| 69 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.54619010 |
| 70 | Pertussis_Homo sapiens_hsa05133 | 0.53463358 |
| 71 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.51736200 |
| 72 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.51206836 |
| 73 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.49776561 |
| 74 | Malaria_Homo sapiens_hsa05144 | 0.47470961 |
| 75 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.45350593 |
| 76 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.45242551 |
| 77 | Lysosome_Homo sapiens_hsa04142 | 0.44432190 |
| 78 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.44409595 |
| 79 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.44157324 |
| 80 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.43512032 |
| 81 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.43460284 |
| 82 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.41927231 |
| 83 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.41691894 |
| 84 | Metabolic pathways_Homo sapiens_hsa01100 | 0.40353671 |
| 85 | Homologous recombination_Homo sapiens_hsa03440 | 0.39181584 |
| 86 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.38732194 |
| 87 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.37085561 |
| 88 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.36869169 |
| 89 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.36064496 |
| 90 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.35344211 |
| 91 | Purine metabolism_Homo sapiens_hsa00230 | 0.33104300 |
| 92 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.31438358 |
| 93 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.30442791 |
| 94 | Shigellosis_Homo sapiens_hsa05131 | 0.30413082 |
| 95 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.28877417 |
| 96 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.28234676 |
| 97 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.28060591 |
| 98 | Legionellosis_Homo sapiens_hsa05134 | 0.26034847 |
| 99 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.24838648 |
| 100 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.21873556 |

